Healthcare & Life Sciences AI Summit

The Healthcare & Life Sciences AI Summit is organized by American Conference Institute (ACI), part of C5 Group.

ACI’s 4th Annual Healthcare & Life Sciences AI Summit brings together legal, regulatory, compliance, privacy and AI leaders from across the healthcare ecosystem to address responsible use of AI: from discovery and commercialization through deployment and patient care. The program focuses on AI governance, regulation, privacy, cybersecurity, contracting, enforcement, liability and practical oversight across life sciences and healthcare delivery.

The conference will take place February 23–24, 2027, at the New York City Bar, 42 W 44th St, New York, NY 10036. While the event is hosted at the New York City Bar offices, this is not a New York City Bar event. Attendance is open to all professionals regardless of membership status or legal background.

The Summit is designed for professionals responsible for legal, compliance and risk; AI, data and technology; regulatory and clinical functions; and business and operations. Relevant roles include General Counsel, Chief Legal Officers, AI/Digital and Regulatory Counsel, privacy and cybersecurity leaders, Chief AI Officers, Responsible AI and AI governance professionals, regulatory affairs and FDA strategy teams, clinical development and R&D leaders, procurement, vendor management, Health IT, reimbursement, managed care, digital health and clinical operations.

The conference is designed for professionals from pharmaceutical, biotech, MedTech, medical device, diagnostics, hospital, health system, provider, payer, managed care, digital health, CRO, Health IT, AI/technology, law firm and consulting organizations.

Topics include AI regulation, governance and accountability; privacy, cybersecurity and AI risk; FDA expectations; clinical trials and AI-generated evidence; intellectual property and transactions; AI-enabled drug and device development; clinical decision support; physician liability; payer algorithms; reimbursement; procurement; patient-facing AI; contracting; enforcement and emerging liability.

Attendees will learn practical approaches for AI inventories, validation, monitoring, risk assessment and human oversight, while tracking evolving FDA, U.S. state, federal and global requirements. The program also addresses vendor contracting, privacy, cybersecurity, investigations and liability, as well as how organizations are measuring AI performance, prioritizing use cases, demonstrating ROI and sharing results with stakeholders.

Past editions have featured senior in-house legal, compliance, privacy, regulatory, digital, AI, data and intellectual property leaders from life sciences and healthcare organizations, alongside law firm partners, technology and consulting professionals, and government or regulatory speakers. Faculty details for the 2027 Summit will be announced as they become available.

Please refer to the conference website for the latest speaker and faculty announcements.

The Summit offers networking breakfasts, scheduled networking breaks, networking luncheons and a Day One cocktail reception, creating opportunities to connect with peers across life sciences, healthcare, legal, compliance, AI and technology. The 2027 networking schedule will be available as the agenda is published.

Yes. Groups of 4–8 attendees from the same organization or firm receive a 10% conference discount, while groups of 9–12 receive a 15% discount. Groups of more than 12 should call 1-888-224-2480; team members must register together in one transaction.

For the most up-to-date information on delegate substitutions and cancellations for American Conference Institute events, please review by clicking on Delegate Substitutions and Cancellation policy here.

ACI has arranged a limited number of rooms at a negotiated rate at Sofitel New York, 45 W 44th St, New York, NY 10036. Contact the hotel directly and quote “ACI Life Sciences AI”; the guest room block cut-off date is January 22, 2027, and availability and the negotiated rate cannot be guaranteed after that date or once the room block fills.

Accreditation will be sought in jurisdictions requested by registrants that have continuing education requirements. This course is identified as non-transitional for CLE accreditation. ACI certifies that this activity has been approved for CLE credit by the New York State Continuing Legal Education Board and the State Bar of California. ACI has a dedicated team that processes requests for state approval; event accreditation varies by jurisdiction.